Jin Ku Lee

Title: Jin Ku Lee: Innovator in Cancer Treatment

Introduction

Jin Ku Lee is a prominent inventor based in Seoul, South Korea. He is known for his significant contributions to the field of biotechnology, particularly in cancer treatment. His innovative work has led to the development of a unique antibody that targets neuropilin 1, a protein involved in cancer progression.

Latest Patents

Jin Ku Lee holds a patent for an "Antibody binding to neuropilin 1 and use thereof." This patent encompasses an antibody that binds to Neuropilin 1 (NRP1) or an antigen-binding fragment thereof. It also includes a nucleic acid encoding the antibody, a vector containing the nucleic acid, and a cell transformed with the vector. Furthermore, the patent details a method for preparing the antibody or its fragments, an antibody-drug conjugate, and a composition for preventing or treating cancer. He has 1 patent to his name.

Career Highlights

Throughout his career, Jin Ku Lee has worked with notable organizations, including the Samsung Life Public Welfare Foundation and Aimed Bio Inc. His experience in these companies has allowed him to advance his research and contribute to innovative solutions in healthcare.

Collaborations

Jin Ku Lee has collaborated with several professionals in his field, including Do-Hyun Nam and Yeup Yoon. These collaborations have fostered a productive environment for research and development, enhancing the impact of his work.

Conclusion

Jin Ku Lee's contributions to cancer treatment through his innovative antibody research highlight his role as a key inventor in biotechnology. His work continues to pave the way for advancements in medical science and patient care.